Legend Biotech Corporation (LEGN)
NASDAQ: LEGN · Real-Time Price · USD
18.90
+0.27 (1.45%)
At close: Oct 22, 2026, 4:00 PM EDT
18.74
-0.16 (-0.87%)
After-hours: Oct 22, 2026, 5:33 PM EDT
Legend Biotech Market Cap
Legend Biotech has a market cap or net worth of $3.66 billion as of October 22, 2026. It is the 4,563rd most valuable company in the world and the 1,385th biggest in the United States. Its market cap has decreased by 39.62% in one year.
Market Cap
3.66B
Enterprise Value
2.98B
1-Year Change
-39.62%
Global Rank
Country Rank
#1,385 United States
Category
ChartMarket Cap Chart
Since June 5, 2020, Legend Biotech's market cap has decreased from $4.79B to $3.66B, a decrease of -23.48%. That is a compound annual growth rate of -4.11%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 22, 2026 | 3.66B | -8.79% |
| Dec 31, 2025 | 4.02B | -32.74% |
| Dec 31, 2024 | 5.97B | -45.43% |
| Dec 29, 2023 | 10.94B | 30.89% |
| Dec 30, 2022 | 8.36B | 16.46% |
| Dec 31, 2021 | 7.18B | 92.11% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 5, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Relay Therapeutics | 4.02B |
| Arcutis Biotherapeutics | 4.01B |
| AbCellera Biologics | 3.97B |
| Xenon Pharmaceuticals | 3.49B |
| Acadia Pharmaceuticals | 3.48B |
| Parabilis Medicines | 3.43B |
| IDEAYA Biosciences | 3.42B |
| Tarsus Pharmaceuticals | 3.12B |